FTRE Q3 2024 Earnings — Fortrea Holdings Inc. Revenue & Financial Results | Market Cap Arena

FTREFortrea Holdings Inc.

$851M

Q3 2024 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$675M-5.4% YoY

Gross Profit

$148M22.0% margin

Operating Income

-$18M-2.7% margin

Net Income

-$28M-4.1% margin

EPS (Diluted)

$-0.31

QoQ Revenue Growth

+1.9%

Cash Flow

Operating Cash Flow

-$2M

Free Cash Flow

-$11M

Stock-Based Comp.

$13M

Balance Sheet

Total Assets

$3.7B

Total Liabilities

$2.2B

Stockholders' Equity

$1.5B

Cash & Equivalents

$105M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$675M	$714M	-5.4%
Gross Profit	$148M	$150M	-1.1%
Operating Income	-$18M	$10M	-274.8%
Net Income	-$28M	-$14M	-99.3%

Geographic Segments

North America

$320M47%

Europe

$192M28%

Other Geographical Areas

$163M24%